Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 3
2010 4
2011 2
2012 2
2013 8
2014 11
2015 6
2016 4
2017 7
2018 7
2019 3
2020 1
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T, Kater AP, Niemann CU, Gonzalez D, Davi F, Gonzalez Diaz M, Moreno C, Gaidano G, Stamatopoulos K, Rosenquist R, Stilgenbauer S, Ghia P, Pospisilova S; European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network. Malcikova J, et al. Leukemia. 2018 May;32(5):1070-1080. doi: 10.1038/s41375-017-0007-7. Epub 2018 Feb 2. Leukemia. 2018. PMID: 29467486 Free PMC article. Review.
Editorial: Biology and treatment of high-risk CLL.
Tausch E, Malcikova J, Riches JC, Edelmann J. Tausch E, et al. Among authors: malcikova j. Front Oncol. 2023 Feb 20;12:1109950. doi: 10.3389/fonc.2022.1109950. eCollection 2022. Front Oncol. 2023. PMID: 36891501 Free PMC article. No abstract available.
TP53 aberrations in chronic lymphocytic leukemia.
Trbusek M, Malcikova J. Trbusek M, et al. Among authors: malcikova j. Adv Exp Med Biol. 2013;792:109-31. doi: 10.1007/978-1-4614-8051-8_5. Adv Exp Med Biol. 2013. PMID: 24014294 Review.
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.
Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP, Cymbalista F, Eichhorst B, Hallek M, Döhner H, Hillmen P, van Oers M, Gribben J, Ghia P, Montserrat E, Stilgenbauer S, Zenz T; European Research Initiative on CLL (ERIC). Pospisilova S, et al. Among authors: malcikova j. Leukemia. 2012 Jul;26(7):1458-61. doi: 10.1038/leu.2012.25. Epub 2012 Feb 2. Leukemia. 2012. PMID: 22297721 Review.
ToTem: a tool for variant calling pipeline optimization.
Tom N, Tom O, Malcikova J, Pavlova S, Kubesova B, Rausch T, Kolarik M, Benes V, Bystry V, Pospisilova S. Tom N, et al. Among authors: malcikova j. BMC Bioinformatics. 2018 Jun 26;19(1):243. doi: 10.1186/s12859-018-2227-x. BMC Bioinformatics. 2018. PMID: 29940847 Free PMC article.
Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?
Pospisilova S, Sutton LA, Malcikova J, Tausch E, Rossi D, Montserrat E, Moreno C, Stamatopoulos K, Gaidano G, Rosenquist R, Ghia P; European Research Initiative on CLL (ERIC). Pospisilova S, et al. Among authors: malcikova j. Haematologica. 2016 Mar;101(3):263-5. doi: 10.3324/haematol.2015.139246. Haematologica. 2016. PMID: 26928246 Free PMC article. No abstract available.
54 results